oxymetazoline has been researched along with Apnea in 1 studies
Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.
Apnea: A transient absence of spontaneous respiration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gopalakrishnan, S | 1 |
| Sodhi, K | 1 |
1 other study available for oxymetazoline and Apnea
| Article | Year |
|---|---|
Recurrent Apnea in a Neonate Following Intranasal Oxymetazoline.
Topics: Apnea; Humans; Infant, Newborn; Infant, Premature; Male; Oxymetazoline; Retrospective Studies; Sympa | 2016 |